arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Teladoc Health, Inc.

TDOC
$7.12 ▲ +0.43 (+6.50%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
14 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

Teladoc Health, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3B
Dividend Yield
Revenue Growth -1.5%
Op. Margin -10.4%
ROIC -16.1%
FCF / Share $1.62
Trailing P/E
Price / Book 0.9x
FCF Yield 22.8%
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.53B
↓ -1.5%
Net Income Profit after all expenses
$-200.32M
↑ +80.0%
Operating Margin Operating profit as % of sales
-10.4%
↑ +73.8% 15th
FCF / Share Free cash flow per share
$1.62
↓ -2.3%
Long-Term Debt Long-term obligations
$44.42M
↑ +67.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
33
Returns
31
Cash Quality
8

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 52 quarters